Ark Invest purchased a significant number of shares of Tempus AI, despite the company’s stock tumbling after reporting mixed fourth-quarter financial results. The firm’s ARK Genomic Revolution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback